Spravato Treatment in Mineola, Long Island | Nao Medical

Nao Medical provides FDA-approved Spravato® (esketamine) treatment in Mineola for eligible adults with treatment-resistant depression and certain adults with major depressive disorder based on clinical evaluation. This location is part of Nao Medical's multi-location Spravato program across New York City and Long Island, giving patients local access to monitored in-office treatment, insurance support, and ongoing psychiatric follow-up.

Why patients choose Nao Medical for Spravato in Mineola

Spravato treatment works best when logistics do not fall apart between evaluation, authorization, dosing, and follow-up. Nao Medical built this program to reduce that friction. Mineola is a strong Long Island access point for patients who need reliable follow-through on prior auth, scheduling, and ongoing treatment coordination.

What treatment looks like at our Mineola Spravato clinic

Treatment starts with a clinical evaluation to confirm whether Spravato is appropriate. Once eligibility and benefits are reviewed, your care team schedules monitored in-office sessions at this location. Patients self-administer the nasal spray under supervision and remain in the clinic for observation after dosing.

Your care manager stays involved across the process: helping with prior auth status, first-visit preparation, treatment scheduling, and communication about next steps. If you are already working with a psychiatrist, we can coordinate care rather than forcing you to start over.

Insurance and Medicaid coverage for Spravato in Mineola

Nao Medical emphasizes access. Eligible patients at our Mineola location can use Medicaid, Medicare, Medicare Advantage, and many commercial plans for Spravato treatment. That includes New York Medicaid Managed Care plans such as Healthfirst, Fidelis Care, MetroPlus, and United Healthcare Community Plan, along with major plans like Aetna, Blue Cross Blue Shield, Cigna, EmblemHealth, and others listed on our main Spravato insurance section.

Coverage is still plan-specific, which is why the program includes benefits verification before treatment begins. If you do not know whether your plan covers Spravato, the care team can review likely requirements and help you understand the next step.

Convenient for patients in Long Island

Our Mineola clinic is located at 135 Mineola Blvd, Mineola, NY 11501 and serves patients coming from Mineola, Garden City, Carle Place, Westbury, Uniondale, Hempstead, and surrounding Nassau County communities. For many patients, having a local Spravato option matters because treatment requires repeated monitored visits rather than a single one-time appointment.

If Mineola is not the best fit for your commute or schedule, you can also start with our main Spravato treatment hub or review other Nao Medical Spravato locations below.

Frequently Asked Questions About Spravato in Mineola

Do you accept Medicaid and Medicare for Spravato treatment in Mineola?

Yes. Nao Medical accepts Medicaid, Medicare, Medicare Advantage, and major commercial insurance plans for eligible Spravato patients in Mineola. Coverage still depends on benefits, diagnosis, and prior authorization requirements.

Do I need prior authorization before starting Spravato?

Often, yes. Many plans require documentation of diagnosis, prior antidepressant trials, and medical necessity. Every Spravato patient at Nao Medical is assigned a care manager who helps move benefits verification and prior authorization forward.

Will I have a care manager during treatment?

Yes. Every Spravato patient is assigned a care manager who helps coordinate insurance questions, prior authorization updates, scheduling, first-visit preparation, and next-step communication.

Can Nao Medical handle psychiatric evaluation and prescribing in Mineola?

Yes. Nao Medical can handle psychiatric evaluation, prescribing, and ongoing management for eligible Spravato patients in Mineola. If you already have a psychiatrist, our team can also coordinate with that clinician when appropriate.

Do I need a ride home after each Spravato session?

Yes. Spravato is given in-office with monitoring, and patients should not drive after treatment. Your care team will review transportation planning with you, and transportation coordination may be available when supported by your insurance coverage.

Will my blood pressure and side effects be monitored during treatment?

Yes. Spravato treatment involves direct clinical supervision, including monitoring for side effects after dosing. The care team may check blood pressure before treatment and again during the monitored recovery period based on clinical protocols.

How long are Spravato visits and how often do I come in?

Patients typically stay in the clinic for at least two hours after dosing for monitoring. For treatment-resistant depression, many adults start with twice-weekly visits during the first month, then space visits out over time based on response, tolerability, and provider guidance.

Other Nao Medical Spravato locations

Nao Medical also offers active Spravato treatment across New York City and Long Island. If you are comparing commute times or looking for a different neighborhood, these locations may also help: